Abstract
A vast literature exists on the relationship between nutrition, nutrition-related risk factors, and the contemporary epidemic of atherosclerotic disease — especially coronary heart disease — in the industrialized countries (1–4). At the onset in this survey, it is worth emphasizing a point often forgotten due to the understandable preoccupation of atherosclerosis researchers with composition (quality) of the diet — especially lipid composition as it affects serum cholesterol: Nutrition is involved in the etiology of atherosclerotic disease not only via composition of the diet, especially saturated fat and cholesterol intake and the influence of these on serum cholesterol. Quantity is also important. Total caloric intake influences risk, i.e., imbalance between consumption and expenditure, expecially when (as in industrialized populations) the diet tends to be high in saturated fats and cholesterol. The consequence is not only obesity — a common phenomenon among adults in developed countries, even among children and teenagers in the United States — but frequently also obesityrelated hypertriglyceridemic hypercholesterolemia, hypertension, hyperglycemia and hyperuricemia, all implicated as risk factors for atherosclerotic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Katz, L.N., Stamler, J. and Pick, R.P. Nutrition and Atherosclerosis, Lea and Febiger, Philadelphia, Pa., 1958.
Stamler, J. Lectures on Preventive Cardiology, Grune and Stratton, New York, N.Y., 1967.
Stamler, J., Berkson, D.M. and Lindberg, H.A. Risk Factors: Their Role in the Etiology and Pathogenesis of the Atherosclerotic Diseases. Wissler, R.W. and Geer, J.C., eds., Pathogenesis of Atherosclerosis, Williams and Wilkins, Baltimore, Md., p. 41, 1972.
Inter-Society Commission for Heart Disease Resources. Atherosclerosis Study Group and Epidemiology Study Group. Primary Prevention of the Atherosclerotic Diseases. Circulation, 42: A55, 1970.
Rosenthal, S.R. Studies in Atherosclerosis: Chemical, Experimental and Morphologic. Arch. Path., 18: 473, 660 and 827, 1934.
Yerushalmy, J. and Hilleboe, H.E. Fat in the Diet and Mortality from Heart Disease — A Methodological Note. New York State J. Med., 57: 2343, 1957.
Jolliffe, N. and Archer, M. Statistical Associations between International Coronary Heart Disease Death Rates and Certain Environmental Factors. J. Chron. Dis., 9: 636, 1959.
Connor, W.E. Dietary Cholesterol and the Pathogenesis of Atherosclerosis. Geriatrics, 16: 407, 1961.
Yudkin, J. Diet and Coronary Thrombosis-Hypothesis and Fact. Lancet, 2: 155, 1957.
Stamler, J., Stamler, R. and Shekelle, R. Regional Differences in Prevalence, Incidence and Mortality from Atherosclerotic Coronary Heart Disease. de Haas, J.H., Hemker, H.C. and Snellen, H.A., eds. Ischaemic Heart Disease, Leiden University Press, Leiden, The Netherlands, p. 84, 1970.
Masironi, F. Dietary Factors and Coronary Heart Disease. Bull. WHO, 42: 103, 1970.
McGill, H.C., Jr., ed. Geographic Pathology of Atherosclerosis, Williams and Wilkins, Baltimore, Md., 1968.
Keys, A., ed. Coronary Heart Disease in Seven Countries. Circulation, 41: Suppl. 1, 1970.
Keys, A. Letter to the Editors. Atherosclerosis, 18: 352, 1973.
Yudkin, J. and Morland, J. Sugar Intake and Myocardial Infarction. Amer. J. Clin. Nutr., 20: 503, 1967.
Stamler, J. Nutrition, Metabolism and Atherosclerosis — A Review of Data and Theories, and a Discussion of Controversial Questions. Ingelfinger, F.J., Reiman, A.S. and Finland, M., eds. Controversy in Internal Medicine, W.B. Saunders Co., Philadelphia, Pa., p. 27, 1966.
Walker, A.R.P. Sugar Intake and Coronary Heart Disease. Atherosclerosis, 14: 137, 1971.
Coronary Drug Project Research Group. Factors Influencing Long-Term Prognosis after Recovery from Myocardial Infarction — Three-Year Findings of the Coronary Drug Project. J. Chron. Dis., In press.
Coronary Drug Project Research Group. The Natural History of Myocardial Infarction in the Coronary Drug Project: Prognostic Importance of Serum Lipid Levels, In press.
Feinleib, M., Kannel, W.B., Tedeschi, C.G., Landau, T.K. and Garrison, R.J. The Relation of Ante Mortem Characteristics to Cardiovascular Findings at Necropsy: The Framingham Study. Paper presented at the Conference on Cardiovascular Disease Epidemiology, Council on Epidemiology, American Heart Association, San Diego, Calif.,Mar. 1–2, 1971.
Committee on Reduction of Risk of Heart Attack and Stroke, American Heart Association. Coronary Risk Handbook — Estimating Risk of Coronary Heart Disease in Daily Practice, American Heart Association, EM620-PE, New York, N.Y., 1973.
Gofman, J.W. et al. and Andrus, E.C. et al. Evaluation of Serum Lipoprotein and Cholesterol Measurements as Predictors of Clinical Complications of a Cooperative Study of Lioproteins and Atherosclerosis. Circulation, 14: 691, 1956.
Kannel, W.B., Castelli, W.P., Gordon, T. and McNamara, P.M. Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study. Ann. Intern. Med., 74: 1, 1971.
Cofman, J.W., Young, W. and Tandy, R. Ischemic Heart Disease, Atherosclerosis, and Longevity. Circulation, 34: 679, 1966.
Carlson, L.A. and Böttiger, L.E. Ischaemic Heart-Disease in Relation to Fasting Values of Plasma Triglycerides and Cholesterol. Lancet, 1: 865, 1972.
Stamler, J., Schoenberger, J.A., Lindberg, H.A., Shekelle, R., Stoker, J.M., Epstein, M.B., deBoer, L., Stamler, R., Restivo, R., Gray, D. and Cain, W. Detection of Susceptibility to Coronary Disease. Bull. N.Y. Acad. Med., 45: 1306, 1969.
Schoenberger, J.A., Stamler, J., Shekelle, R.B. and Shekelle, S. Current Status of Hypertension Control in an Industrial Population. J.A.M.A., 222: 559, 1972.
Stamler, J., Schoenberger, J.A., Shekelle, R.B. and Stamler, R. Hypertension: The Problem and the Challenge. The Hypertension Handbook, Merck, Sharp and Dohme, West Point, Pa., p. 3, 1974.
Stamler, J., Shekelle, R.B., Schoenberger, J.A. and Shekelle, S. Glycemia and Its Relationships to Other Risk Factors and ECG Abnormalities in 35,000 Employed Chicagoans. Paper presented at the Conference on Cardiovascular Epidemiology, Council on Epidemiology, American Heart Association, New Orleans, La., Mar. 12–13, 1973.
Stamler, J., Stamler, R. and Berkson, D.M. Is Hyperglycemia and Independent and Additive Risk Factor for Coronary Heart Disease? — Findings of the Community Screening Program of the Chicago Board of Health. In preparation.
University Group Diabetes Program. The University Group Diabetes Program — A Study of the Effects of Hypoglycemic Agents on Vascular Complications in Patients with Adult-Onset Diabetes. Diabetes, 19: 747, 1970.
University Group Diabetes Program. Effects of Hypoglycemic Agents on Vascular Complications in Patients with Adult-Onset Diabetes: IV. A Preliminary Report on Phenformin Results. J.A.M.A., 217: 777, 1971.
Ackerknecht, E.H. Rudolf Virchow — Doctor, Statesman, Anthropologist, University of Wisconsin Press, Madison, Wisc., 1953.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Stamler, J. (1975). Diet-Related Risk Factors for Human Atherosclerosis: Hyperlipidemia, Hypertension, Hyperglycemia — Current Status. In: Sirtori, C., Ricci, G., Gorini, S. (eds) Diet and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 60. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9029-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9029-3_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9031-6
Online ISBN: 978-1-4615-9029-3
eBook Packages: Springer Book Archive